Showing results (111-120 of 128) with videos related to
Sort By:
Pageof 13
Frontiers in Oncology|February 23, 2023
Syngeneic model of carcinogen-induced tumor mimics basal/squamous, stromal-rich, and neuroendocrine molecular and immunological features of muscle-invasive bladder cancerShruti D Shah, Bryan M Gillard, Michelle M Wrobel, et al.Nature Biotechnology|September 15, 2015
Engineering pulmonary vasculature in decellularized rat and human lungsXi Ren, Philipp T Moser, Sarah E Gilpin, et al.Biomaterials|February 9, 2019
Biofabrication of a vascularized islet organ for type 1 diabetesAntonio Citro, Philipp T Moser, Erica Dugnani, et al.Oncotarget|April 29, 2020
Superior cancer preventive efficacy of low versus high dose of mTOR inhibitor in a mouse model of prostate cancerMarina P Antoch, Michelle Wrobel, Bryan Gillard, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 6, 2004
Augmentation of T cell levels and responses induced by androgen deprivationAnja C Roden, Michael T Moser, Samuel D Tri, et al.HNO|October 17, 2006
[Diagnosis and therapy of auditory synaptopathy/neuropathy]T Moser, N Strenzke, A Meyer, et al.Tissue Engineering. Part A|October 31, 2019
Creation of Laryngeal Grafts from Primary Human Cells and Decellularized Laryngeal ScaffoldsPhilipp T Moser, Mattia Gerli, Gillian R Diercks, et al.Circulation Research|October 28, 2015
Bioengineering Human Myocardium on Native Extracellular MatrixJacques P Guyette, Jonathan M Charest, Robert W Mills, et al.American Journal of Clinical and Experimental Urology|January 7, 2022
Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartmentMichalis Mastri, Swathi Ramakrishnan, Shruti D Shah, et al.Cancer Research|November 15, 2012
Definition of molecular determinants of prostate cancer cell bone extravasationSteven R Barthel, Danielle L Hays, Erika M Yazawa, et al.Pageof 13